BioCentury
ARTICLE | Clinical News

Topical benzoporphyrin derivative: Began a Phase I/II trial

November 14, 1994 8:00 AM UTC

Quadra Logic Technologies Inc. (QLTIF), Vancouver Product: Topical benzoporphyrin derivative (BPD) activated by light-emitting diodes (LEDs) Indication: Moderate to severe psoriasis, covering less tha...